Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Werner syndrome RecQ helicase (WRN) is a nuclear protein with both ATP-dependent 3′→5′ DNA helicase and 3′→5′ exonuclease activities, essential for maintaining genome stability, telomere maintenance, and DNA repair. Mutations in WRN cause Werner syndrome, a premature aging disorder. WRN interacts with proteins involved in DNA replication, repair, and chromatin structure.
Helicase inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Werner Syndrome RecQ Helicase (WRN).